The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $285.41 in the prior trading day, AMGEN Inc (NASDAQ: AMGN) closed at $286.0, up 0.21%. In other words, the price has increased by $0.21 from its previous closing price. On the day, 3.05 million shares were traded. AMGN stock price reached its highest trading level at $287.2 during the session, while it also had its lowest trading level at $281.7125.
Ratios:
Our goal is to gain a better understanding of AMGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.52. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 7.57 whereas as Long-Term Debt/Eq ratio is at 7.24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’25 when Grygiel Nancy A. sold 1,267 shares for $296.99 per share. The transaction valued at 376,280 led to the insider holds 7,209 shares of the business.
Grygiel Nancy A. bought 1,267 shares of AMGN for $372,909 on Aug 20 ’25. On Jun 05 ’25, another insider, Khosla Rachna, who serves as the SVP, Business Development of the company, sold 1,500 shares for $289.68 each. As a result, the insider received 434,520 and left with 8,162 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 153971490816 and an Enterprise Value of 202147495936. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.40, and their Forward P/E ratio for the next fiscal year is 13.22. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.43 while its Price-to-Book (P/B) ratio in mrq is 20.73. Its current Enterprise Value per Revenue stands at 5.789 whereas that against EBITDA is 12.518.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.48, which has changed by -0.13574278 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $339.17, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is -1.56%, while the 200-Day Moving Average is calculated to be -0.59%.
Shares Statistics:
The stock has traded on average 2.36M shares per day over the past 3-months and 2983710 shares per day over the last 10 days, according to various share statistics. A total of 538.30M shares are outstanding, with a floating share count of 537.30M. Insiders hold about 0.20% of the company’s shares, while institutions hold 82.17% stake in the company. Shares short for AMGN as of 1756425600 were 11796977 with a Short Ratio of 4.99, compared to 1753920000 on 12519619. Therefore, it implies a Short% of Shares Outstanding of 11796977 and a Short% of Float of 2.1999999999999997.
Dividends & Splits
In the trailing 12 months, AMGN’s forward annual dividend rate was 9.26, compared to 9.39 this year. Against a Trailing Annual Dividend Yield of 0.032444555. The stock’s 5-year Average Dividend Yield is 3.05. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-08-22 with an ex-dividend date of 2025-08-22. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
The current rating of AMGEN Inc (AMGN) is the result of assessments by 24.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $5.12, with high estimates of $5.74 and low estimates of $4.83.
Analysts are recommending an EPS of between $21.62 and $20.64 for the fiscal current year, implying an average EPS of $21.08. EPS for the following year is $21.6, with 30.0 analysts recommending between $23.2 and $20.31.
Revenue Estimates
22 analysts predict $8.98B in revenue for the current quarter. It ranges from a high estimate of $9.2B to a low estimate of $8.78B. As of the current estimate, AMGEN Inc’s year-ago sales were $8.5BFor the next quarter, 22 analysts are estimating revenue of $9.36B. There is a high estimate of $9.66B for the next quarter, whereas the lowest estimate is $9.08B.
A total of 29 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.18B, while the lowest revenue estimate was $35.26B, resulting in an average revenue estimate of $35.7B. In the same quarter a year ago, actual revenue was $33.42BBased on 29 analysts’ estimates, the company’s revenue will be $36.31B in the next fiscal year. The high estimate is $37.92B and the low estimate is $34.74B.
